Prognostic Value of the Pan-Immune-Inflammation Value for Predicting Major Adverse Cardiovascular Events Within One Year After Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction
PIV demonstrates high predictive value for MACE within one year after PCI in patients with STEMI. It may serve as a valuable biomarker for assessing the risk of percutaneous coronary atherosclerosis events in this population. Further multi-center studies are warranted to validate its clinical utility.
Authors
- Hemei Zhang
- Na Zhang (ORCID: https://orcid.org/0000-0002-3433-9921)
- Haitao Zhang (ORCID: https://orcid.org/0000-0002-1639-4089)
- Jiangyue Qu
- Chang Liu
- Xudong Liu
Institutions
- Hainan Medical University (CN)
Publication Details
- Journal
- British Journal of Hospital Medicine
- Published
- 2026-01-26
- DOI
- https://doi.org/10.31083/bjhm50379
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 24.20